Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Psychotic”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableStudy completedNCT03183609
What this trial is testing

Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

Who this might be right for
SchizophreniaGluten SensitivitySchizo Affective Disorder
University of Maryland, Baltimore 40
Not applicableNot Yet RecruitingNCT06563752
What this trial is testing

Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers

Who this might be right for
Schizophrenia
National Yang Ming Chiao Tung University 360
Testing effectiveness (Phase 2)Study completedNCT00074477
What this trial is testing

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250
Testing effectiveness (Phase 2)WithdrawnNCT01272765
What this trial is testing

Anti-psychotic Medication (Stable Dose) Weight Loss Study

Who this might be right for
Obesity
Avera McKennan Hospital & University Health Center
Post-approval studies (Phase 4)Study completedNCT00334035
What this trial is testing

Antipsychotic Therapy and First Episode

Who this might be right for
Schizophrenia
The University of Hong Kong 169
Early research (Phase 1)Study completedNCT00698022
What this trial is testing

A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers

Who this might be right for
Healthy
Corcept Therapeutics 76
Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Post-approval studies (Phase 4)Ended earlyNCT00418873
What this trial is testing

Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

Who this might be right for
Schizophrenia
Astellas Pharma Inc 39
Not applicableStudy completedNCT02118610
What this trial is testing

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 63
Not applicableUnknownNCT02877108
What this trial is testing

Naturalistic Adasuve Clinical Trial Study

Who this might be right for
Agitation
Mt Sinai Hospital, Chicago 100
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Testing effectiveness (Phase 2)Study completedNCT01602029
What this trial is testing

Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 303
Testing effectiveness (Phase 2)Study completedNCT00206544
What this trial is testing

Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

Who this might be right for
Bipolar DisorderManiaSchizoaffective Disorder
The Alfred 51
Testing effectiveness (Phase 2)Study completedNCT02624167
What this trial is testing

Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Newron Pharmaceuticals SPA 90
Post-approval studies (Phase 4)Looking for participantsNCT05823532
What this trial is testing

Anti-Inflammatory Challenge in Schizophrenia

Who this might be right for
Schizophrenia
Emory University 20
Testing effectiveness (Phase 2)Study completedNCT01266174
What this trial is testing

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

Who this might be right for
Cognitive ImpairmentSchizophrenia
Amarantus BioScience Holdings, Inc. 31
Early research (Phase 1)Study completedNCT00929955
What this trial is testing

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 36
Not applicableStudy completedNCT01793935
What this trial is testing

Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
K.N. Roy Chengappa 68
Not applicableWithdrawnNCT02661347
What this trial is testing

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Who this might be right for
SchizophreniaSchizophreniformSchizoaffective Disorder+1 more
Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT05240976
What this trial is testing

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 80
Load More Results